Companies / VIT

VITURA HEALTH LIMITED

ASX:VITHealth Care Equipment & Services
662.7M shares on issueASX (delayed) · as of 28 July 2026$0.028price · delayed$19.9Mmarket cap · indicative
B
Dilution grade

Share count grew 14% in 24 months; 1 cash raise in 24 months

Cash runwayno data — not a quarterly (4C/5B) cash filer
Share-count growth (24m)13.9%
Raise cadence (24m)1 cash raise
Options & rights overhang3.2% of shares
In-the-money supply0.0% of shares
Pending proposed issuesnone

VITURA HEALTH LIMITED's ordinary share count increased 13.9% between November 2024 and September 2025 to 663M shares. The company completed one capital raise in the 24-month window for total proceeds of A$5.2M, most recently received in February 2025. Options and rights could convert into 21M new shares, equal to 3.2% of the current share count, with the nearest expiry in August 2031 and 0% of current shares in the money. The company does not have a current quarterly cash report on the record, so no quarterly cash balance or funding-runway figure is disclosed. No proposed securities issues (Appendix 3B) are pending.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
3.2%
Max option dilution
0.0%
ITM option dilution
0
Raises · last 12 months
—
Cash cover · not a quarterly filer

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 662.7M per ASX (delayed) (28 July 2026).
598.7M622.2M645.7MDec 24Sept 25July 26Cash raise · 12 Feb 2025

Cash runway

Not a quarterly cash filer. This company does not lodge Appendix 4C/5B quarterly cash reports, so cash runway does not apply.

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
27 July 20263H · cancellationVIT : ORDINARY FULLY PAID662.7MAppendix 3H
29 Mar 20263H · cancellationVIT : ORDINARY FULLY PAID662.7MAppendix 3H
12 Mar 20263H · cancellationVIT : ORDINARY FULLY PAID662.7MAppendix 3H
3 Feb 20263H · cancellationORDINARY FULLY PAID662.7MAppendix 3H
11 Jan 20263H · cancellationVIT : ORDINARY FULLY PAID662.7MAppendix 3H
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

1 cash raise in the last 24 months · 0 in the last 12 months

$5.2M
Capital raise
12 Feb 2025
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

3.2%
Total overhang · of current shares
0.0%
In the money · at current price
21.3M
Potential new shares
Aug 2031
Nearest expiry
Paid plan
Per-line options & expiry cliffs
Each option line — code, strike, expiry, quantity and ITM value — plus the expiry-cliff chart.
Join the waitlist

Director dealings

DateDirectorTypeSharesOptionsValueSource
4 June 2026Robert IervasiOther804k——3Y notice
30 Sept 2025Gerard Fogarty AOOther10k——3Y notice
4 Mar 2025Gerard Paul Fogarty AOBuy332k——3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

27 July 2026Notification of cessation of securities - VIT
22 July 2026Vitura announces new senior appointments
8 July 2026Change of Address
4 June 2026Appointment of Interim Chief Financial Officer
4 June 2026Change of Director's Interest Notice
2 June 2026Chief Financial Officer Resignation
26 May 2026Ceasing to be a substantial holder
26 May 2026Change in substantial holding
19 May 2026$PFormer CEO Legal Action Initiated
27 Apr 2026$PBusiness Transformation Update
20 Apr 2026$PDoctors on Demand Performance Update
7 Apr 2026Final Director's Interest Notice
7 Apr 2026Resignation of Non-Executive Director
1 Apr 2026$PAppointment of Chief Executive Officer
29 Mar 2026Notification of cessation of securities - VIT
22 Mar 2026Cortexa advances commercialisation of MDMA supply
16 Mar 2026$PVIT enters distribution agreement with MedReleaf Australia
12 Mar 2026Notification of cessation of securities - VIT
25 Feb 2026$PH1 FY26 Investor Presentation
25 Feb 2026$PH1 FY26 Results Release

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.